Biophytis
Business Services · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Sorbonne Université Bâtiment A 05 Place ...Phone Number
+33 176284083Website
www.biophytis.comRevenue
<$5 MillionStock Symbol
ALBPSIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Biophytis
Biophytis is a clinical-stage biotechnology company developing therapeutics to treat age-related and degenerative diseases, with a focus on muscle loss, respiratory decline, and metabolic disorders. Its lead candidate, BIO101, is being evaluated in global clinical trials for conditions like sarcopenia, Duchenne muscular dystrophy, and obesity.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biophytis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Biophytis has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Biophytis, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Biophytis is spiking on competitors!
Earning: See what the market has to say on Biophytis recently announced quarterly report
Click to see if Biophytis had a recent Job posting/layoffs
Product Launch: Get notified when Biophytis launches new products
Check if Biophytis has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Biophytis
Recommended Actions
Find VP level buyers at Biophytis
Find 3 more new buyers
Company Profile Activity
Activity Insights
Biophytis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Biophytis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Biophytis.
Biophytis financials insights
Gather financial insights about Biophytis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Share Placement
$6.9M
Share Placement
$11.7M
2021
Debt
$38.1M
2025
Private Equity
$8.9M
2026
Private Equity
$1.6M
Biophytis Tech Stack
A closer look at the technologies used by Biophytis
Most Recent Scoops
Funding
Funding
Funding
Funding
Funding
Funding
Event
Biophytis News & Media
Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics
Biophytis and LynxKite launch new modalities beyond MASSIVE: AI-driven drug discovery for next-generation longevity therapies This partnership will generate revenue through: A computational longevity platform, including unique curated datasets and accelerated computation methods relevant...Biophytis enters strategic agreement in Asia and secures $20 million for launch of Phase 3 ...
Biophytis announces strategic agreement in Asia and secures $20 million for Phase 3 trial in sarcopenia, including creation of joint venture in Hong Kong and financing over 3 yearsBiophytis Secures Non-Dilutive Bond Financing Line of up to €1 Million - WebDisclosure
Biophytis secures a non-dilutive bond financing line of up to €1 million with Hexagon Capital Fund to support OBA101 program development and strengthen cash positionBiophytis Secures €8.6 Million for Obesity Program - WebDisclosure
Biophytis announces new cash contribution and debt conversion totaling €8.6 million to finance obesity program. Strategic financial transaction strengthens company's financial structure for future development
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biophytis
Sign Up For FreeTo access detailed company insights
Biophytis is a clinical-stage biotechnology company developing therapeutics to treat age-related and degenerative diseases, with a focus on muscle loss, respiratory decline, and metabolic disorders. Its lead candidate, BIO101, is being evaluated in global clinical trials for conditions like sarcopenia, Duchenne muscular dystrophy, and obesity.... Read More
